Home1801 • HKG
add
Innovent Biologics Inc
Previous close
$48.35
Day range
$45.45 - $48.15
Year range
$28.65 - $52.15
Market cap
76.06B HKD
Avg Volume
21.43M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.73B | 56.07% |
Operating expense | 2.24B | 34.63% |
Net income | 148.99M | 133.53% |
Net profit margin | 5.45 | 121.49% |
Earnings per share | — | — |
EBITDA | -92.88M | 74.96% |
Effective tax rate | 5.09% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.88B | -28.13% |
Total assets | 21.60B | 4.73% |
Total liabilities | 8.48B | 4.75% |
Total equity | 13.12B | — |
Shares outstanding | 1.63B | — |
Price to book | 6.01 | — |
Return on assets | -1.87% | — |
Return on capital | -2.54% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 148.99M | 133.53% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
Apr 28, 2011
Website
Employees
5,659
